A notable prospective cohort study revealed that high sclerostin levels were correlated with lower cumulative freedom from major cardiovascular events, such as myocardial infarction (MI), stroke, and hospitalizations due to heart failure, indicating an increased overall cardiovascular risk in high-risk populations, such as patients undergoing hemodialysis [16]. This evidence concerns the gene SOST and Stroke.